Coronary Syndrome
📧 Sign up to get email alerts when something new happens for Coronary Syndrome.
Sign up freeTop drugs studied for this disease
-
EMA withdrawal · 2018-09-14EMA Withdrawn: Angiox (Bivalirudin) — The Medicines Company UK Ltd
Angiox (bivalirudin) has been withdrawn from the market in the EU.
-
CLINICAL_TRIALS trial_result · 2018-09-12Clinical Trial Update: Low-dose Ticagrelor in Chinese ACS Patients Undergoing PCI [Phase 4]
Phase 4 clinical trial update evaluating low-dose ticagrelor in Chinese acute coronary syndrome patients undergoing PCI.
-
FDA approval · 2018-09-04FDA Approved: TICAGRELOR — Original Application (Teva Pharmaceuticals, Inc.)
FDA approves Teva's generic ticagrelor (ANDA 208390) as an original application approval for TICAGRELOR.
-
CLINICAL_TRIALS trial_result · 2018-08-13Clinical Trial Update: Study of LC23-1306 in Healthy Male Subjects [Phase 1]
Phase 1 trial of LC23-1306 in healthy male subjects completed; results posted.
-
CLINICAL_TRIALS trial_result · 2018-08-06Clinical Trial Update: A Study of Dalcetrapib in Patients Hospitalized For An Acute Coronary Syndrome (Dal-ACUTE) [Phase 3]
Phase 3 trial update for dalcetrapib in patients hospitalized with acute coronary syndrome has completed; results posted in 2018.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-08-06Clinical Trial Update: Shared Decision Making in the Emergency Department: Chest Pain Choice Trial [NA]
Completed trial evaluating shared decision making in the emergency department for chest pain to aid patient-management decisions.
-
CLINICAL_TRIALS trial_result · 2018-08-02Clinical Trial Update: Study Comparing Ticagrelor With Aspirin for Prevention of Vascular Events in Patients Undergoing CABG [Phase 3]
A Phase 3 trial comparing ticagrelor with aspirin for prevention of vascular events in patients undergoing CABG was terminated.
-
EMA approval · 2018-08-01EMA Authorised: Clopidogrel HCS (clopidogrel (as hydrochloride)) — HCS bvba
The EMA authorised Clopidogrel HCS (clopidogrel hydrochloride) for several cardiovascular indications including peripheral vascular diseases…
-
CLINICAL_TRIALS trial_result · 2018-07-26Clinical Trial Update: Optimum Troponin Cutoffs for ACS in the ED
This clinical trial update notes the completion of a study evaluating optimal troponin cutoffs for diagnosing acute coronary syndrome in the…
-
CLINICAL_TRIALS trial_result · 2018-07-24Clinical Trial Update: Myocardial Infarction With Non-obstructive Coronary Arteries in Turkish Population
Clinical trial in Turkey evaluating patients with acute coronary syndrome and myocardial infarction, focusing on myocardial infarction with …
-
CLINICAL_TRIALS research · 2018-07-24Clinical Trial Update: Study to Evaluate the Care Process and the Quality of STEMI Care
A completed clinical trial evaluating the care process and quality of STEMI care (ST-elevation myocardial infarction).
-
CLINICAL_TRIALS research · 2018-07-18Clinical Trial Update: Systematic Screening for Comorbid Psychological Conditions in Cardiac ACSC Patients With Multimorbidity in the ED
A clinical trial update describes systematic screening for comorbid psychological conditions among patients with acute coronary syndrome and…
-
FDA approval · 2018-07-16FDA Approved: BIVALIRUDIN — Original Application (Meitheal Pharmaceuticals Inc.)
FDA approved Meitheal Pharmaceuticals' original application for generic bivalirudin.
-
CLINICAL_TRIALS trial_result · 2018-07-11Clinical Trial Update: Paradigm Shift in the Treatment of Patients With ACS [Phase 4]
Phase 4 clinical trial update on treatment for acute coronary syndrome. The study status is COMPLETED.
-
CLINICAL_TRIALS trial_result · 2018-07-03Clinical Trial Update: The Computed Tomography-derived Fractional Flow Reserve STAT Trial [NA]
The CT-derived fractional flow reserve STAT trial was terminated, with results posted in July 2018.
-
CLINICAL_TRIALS trial_result · 2018-06-28Clinical Trial Update: Cangrelor vs. Ticagrelor for Early Platelet Inhibition in STEMI [Phase 4]
Phase 4 clinical trial comparing cangrelor (Kengreal) with ticagrelor (Brilinta) for early platelet inhibition in ST-segment elevation myoca…
-
CLINICAL_TRIALS research · 2018-06-25Clinical Trial Update: An Observational Prospective Study to Understand the Usage Pattern of Ticagrelor With ACS (Acute Coronary Syndrome)
This completed observational prospective study examined how ticagrelor is used in patients with acute coronary syndrome.
-
CLINICAL_TRIALS research · 2018-06-20Clinical Trial Update: Ticagrelor Monotherapy After 3 Months in the Patients Treated With New Generation Sirolimus Stent for Acute Coronary Syndrome (TICO Study) [Phase 4]
This clinical trial update discusses the TICO study evaluating ticagrelor monotherapy after 3 months in patients with acute coronary syndrom…
-
FDA approval · 2018-06-19FDA Approved: PRASUGREL — Original Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal Pharmaceuticals LLC's original application for prasugrel, authorizing a generic version of the antiplatelet medication. …
-
CLINICAL_TRIALS trial_result · 2018-06-14Clinical Trial Update: Real Life Long-term Adherence to Ticagrelor After PCI for Acute Coronary Syndromes
This clinical trial update reports real-world, long-term adherence to ticagrelor after PCI in patients with acute coronary syndrome. The stu…
-
CLINICAL_TRIALS trial_result · 2018-06-08Clinical Trial Update: The ACS Ethnicity Platelet Function Study
The ACS Ethnicity Platelet Function Study (NCT01829659) has completed, investigating ethnicity-related differences in platelet function in p…
-
CLINICAL_TRIALS trial_result · 2018-06-06Clinical Trial Update: More Intensive Cardiac Rehabilitation Programs in Less Time [NA]
This completed trial evaluated more intensive cardiac rehabilitation programs delivered in a shorter time frame for patients with acute coro…
-
FDA approval · 2018-06-01FDA Approved: BIVALIRUDIN — Original Application (Mylan Institutional LLC)
FDA approved the original abbreviated new drug application for bivalirudin from Mylan Institutional LLC, enabling the marketing of a generic…
-
FDA approval · 2018-05-25FDA Approved: PLAVIX — Supplemental Application (Sanofi-Aventis U.S. LLC)
The FDA approved a supplemental application for Plavix (clopidogrel) submitted by Sanofi-Aventis U.S. LLC. The approval indicates regulatory…
-
CLINICAL_TRIALS research · 2018-05-25Clinical Trial Update: A Survey of Hospitalizations in Cardiology Units in Sub-Saharan Africa
This clinical trial update describes a survey of hospitalizations in cardiology units across Sub-Saharan Africa. The study covers various ca…